Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats

Hypertension Research

Volumn 29, Issue 5, 2006, Pages 361-368

  Takotori, Shingo ^a,b   Zamami, Yoshito ^b   Mio, Mitsunobu ^a   Kurosaki, Yuji ^b   Kawasaki, Hiromu ^b  

^a SHUJITSU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adrenergic pressor; Calcitonin gene related peptide nerve depressor; Hyperinsulinemia; Pethed rat; Spinal cord stimulation

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; CHOLESTEROL; FRUCTOSE; HEXAMETHONIUM; INSULIN; METHOXAMINE; NITROPRUSSIDE SODIUM; NORADRENALIN; TRIACYLGLYCEROL;

ADRENERGIC NERVE; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC GANGLION; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSOR RESPONSE; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NERVE BLOCK; NONHUMAN; PRESSOR RESPONSE; RAT; SPINAL ANIMAL; SPINAL CORD STIMULATION; SYSTOLIC BLOOD PRESSURE; THORACIC SPINE; TRIACYLGLYCEROL BLOOD LEVEL; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ADRENERGIC FIBERS; ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CHOLESTEROL; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; NITROPRUSSIDE; NOREPINEPHRINE; RATS; RATS, WISTAR; SPINAL CORD; TRIGLYCERIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33745659837     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.361     Document Type: Article

References (37)

1. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-817.
2. Chiristlieb AR, Krolewski AS, Warram JH, Soeldener JS: Is insulin the link between hypertension and obesity? Hypertension 1985; 7 (Suppl II): II-54-II-57.
3. Defronzo RA: The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981; 21: 165-171.
4. Landsberg L: Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986; 236: 1081-1090.
5. Reaven GM, Hoffman BB: A role for insulin in the aetiology and course of hypertension. Lancet 1987; 2: 435-436.
6. Lembo G, Napoli R, Capaldo B, et al: Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 1992; 90: 24-29.
7. Hsueh WA, Law RE: Insulin signaling in the arterial wall. Am J Cardiol 1999; 84: 21J-24J.
8. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A: Insulinemia and blood pressure. Relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am J Hypertens 1990; 3: 521-526.
9. Ferrannini E, Natali A, Capaldo B, Lehtovirt M, Jacob S, Yki-Jarvinen H: Insulin resistance, hyperinsulinemia, and blood pressure. Hypertension 1997; 30: 1144-1149.
10. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
11. Creager MA, Liang CS, Coffman JD: Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985; 21: 165-171.
12. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179.
13. Takatori S, Mizote M, Zamami Y, Kurosaki Y, Kawasaki H: Effects of insulin on vascular responses to spinal cord stimulation and vasoactive agents in pithed rats. Br J Pharmacol 2003; 140: 1137-1145.
14. Suzuki M, Nomura C, Odaka H, Ikeda H: Effect of an insulin sensitizer, pioglitazone, on hypertension in fructose-drinking rats. Jpn J Pharmacol 1997; 74: 297-302.
15. Tobey TA, Mondon CE, Zavaroni I, Reaven GM: Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982; 31: 608-612.
16. Taguchi T, Kawasaki H, Imamura T, Takasaki K: Endogenous calcitonin gene-related peptide mediates nonadrenergic noncholinergic depressor response to spinal cord stimulation in the pithed rat. Circ Res 1992; 71: 357-364.
17. Kawasaki H, Nuki Y, Yamaga N, Kurosaki Y, Taguchi, T: Decreased depressor response mediated by calcitonin gene-related peptide (CGRP)-containing vasodilator nerves to spinal cord stimulation and levels of CGRP mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertens Res 2000; 23: 693-699.
18. Nuki Y, Kawasaki H, Taguchi T, Takasaki K, Wada A: Effects of dorsal rhizotomy on depressor response to spinal cord stimulation mediated by endogenous calcitonin gene-related peptide in the pithed rat. J Neurosurg 1993; 79: 899-904.
19. Kawasaki H, Takasaki K, Saito A, Goto K: Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of rat. Nature 1988; 335: 164-167.
20. Kawasaki H, Nuki C, Saito A, Takasaki K: Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J Pharmacol Exp Ther 1990; 252: 403-409.
21. Kawasaki H, Inaizumi K, Nakamura A, Hobara N, Kurosaki Y: Chronic angiotensin II inhibition increases levels of calcitonin gene-related peptide mRNA of the dorsal root ganglia in spontaneously hypertensive rats. Hypertens Res 2003; 26: 257-263.
22. Hobara N, Gessei-Tsutsumi N, Goda M, et al: Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP) - containing nerves in spontaneously hypertensive rats. Hypertens Res 2005; 28: 465-474.
23. Regalia J, Cai F, Helke C: Streptozotocin-induced diabetes and the neurochemistry of vagal afferent neurons. Brain Res 2002; 938: 7-14.
24. Adeghate E: Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats. Neuropeptides 1999; 33: 227-235.
25. Okada K, Hirano T, Ran J, Adachi M: Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats. Hypertens Res; 27: 293-299.
26. Erdos B, Snipes JA, Miller AW, Busija DW: Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 2004; 53: 1352-1359.
27. Karagiannis J, Reid JJ, Darby I, Roche P, Rand MJ, Li CG: Impaired nitric oxide function in the basilar artery of the obese Zucker rat. J Cardiovasc Pharmacol 2003; 42: 497-505.
28. Miller AW, Hoenig ME, Ujhelyi MR: Mechanisms of impaired endothelial function associated with insulin resistance. J Cardiovasc Pharmacol Ther 1998; 3: 125-134.
29. Verma S, Bhanot S, Yao L, Mcneill JH: Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 1996; 9: 370-376.
30. De Jongh RT, Serne EH, Ijzerman RG, De Vries G, Stehouwer CD: Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529-2535.
31. Lteif A, Mather K: Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages. Can J Cardiol 2004; 20 (Suppl B): 66B-76B.
32. Hasegawa K, Yoshida H, Ura N, Murakami H, Hagiwara M, Shimamoto K: The role of renal natriuretic and depressor systems in insulin-resistant hypertensive rats. Hypertens Res 2004; 27: 501-508.
33. Borst BE: The role of TNF-alpha in insulin resistance. Endocrine 2004; 23: 177-182.
34. Chen XD, Lei T, Xia T, Gan L, Yang ZQ: Increased expression of resistin and tumor necrosis factor-alpha in pig adipose tissue as well as effect of feeding treatment on resistin and cAMP pathway. Diabetes Obes Metab 2004; 6: 271-279.
35. Scheen AJ: Pathophysiology of type 2 diabetes. Acta Clin Belg 2003; 58: 335-341.
36. Iwashima Y, Katsuya T, Ishikawa K, et al: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1323.
37. Yamauchi T, Kamon J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 12: 762-769.